COMMAND: A phase 2 randomized, double-blind, study of defactinib (VS-6063) as maintenance therapy in malignant pleural mesothelioma Meeting Abstract
| Authors: | Kindler, H. L.; Fennell, D. A.; Baas, P.; Krug, L. M.; Zauderer, M. G.; Nowak, A. K.; Gralla, R. J.; Nakano, T.; Joseney-Antoine, M.; Poli, A.; Keegan, M.; Horobin, J. |
| Abstract Title: | COMMAND: A phase 2 randomized, double-blind, study of defactinib (VS-6063) as maintenance therapy in malignant pleural mesothelioma |
| Meeting Title: | 16th World Conference on Lung Cancer (WCLC) |
| Keywords: | mesothelioma; cancer stem cells |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 10 |
| Issue: | 9 Suppl. 2 |
| Meeting Dates: | 2015 Sep 6-9 |
| Meeting Location: | Denver, CO |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-09-01 |
| Start Page: | S748 |
| End Page: | S749 |
| Language: | English |
| ACCESSION: | WOS:000370365103522 |
| PROVIDER: | wos |
| PUBMED: | 26710300 |
| DOI: | 10.1016/S1556-0864(16)30012-0 |
| Notes: | Meeting Abstract: P3.08-014 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
